Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-11

Clinical Trial Update: Portal-724 MEMS for Medication Adherence Patients Taking HCV Medications

View source ↗

Summary

Clinical trial update for Portal-724 MEMS aimed at improving adherence to hepatitis C medications; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Portal-724 MEMS

Snippet

Sponsor: Saint Michael's Medical Center | Conditions: Adherence | Status: COMPLETED | Results posted: 2018-12-11